FTC Suit Alleges Endo (ENDP) Entered into Pay-for-Delay Patent Settlements with Impax (IPXL) and Watson to Delay Generic Versions of Branded Drugs Opana ER and Lidoderm

March 31, 2016 9:41 AM EDT Send to a Friend
The Federal Trade Commission filed a complaint in federal district court alleging that Endo Pharmaceuticals Inc. (Nasdaq: ENDP) and several ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login